Teleflex Incorporated (NYSE: TFX) Stock Competitors & Peer Comparison
See TFX's competitors and their performance on the NYSE and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for TFX and its NYSE peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TFX | $136.27 | +3.30% | 6B | 15.54 | $8.75 | +1.00% |
| ISRG | $382.20 | -2.30% | 140.5B | 41.34 | $9.62 | N/A |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.00% |
| BDX | $189.26 | +4.70% | 51.7B | 14.43 | $13.00 | +2.00% |
| MDLN | $32.94 | -3.47% | 28.7B | 24.85 | $1.36 | N/A |
| WST | $356.46 | +2.85% | 24.8B | 44.29 | $7.97 | +0.25% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| SOLV | $89.16 | +1.96% | 15.2B | 12.37 | $7.10 | N/A |
| COO | $76.71 | +1.25% | 15B | 16.83 | $4.56 | N/A |
| BAX | $26.32 | +1.45% | 13.8B | 12.82 | $2.08 | +0.75% |
Stock Comparison
Intuitive Surgical, Inc. (NASDAQ: ISRG)
TFX vs ISRG Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ISRG has a market cap of 140.5B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ISRG trades at $382.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ISRG's P/E ratio is 41.34. In terms of profitability, TFX's ROE is -0.32%, compared to ISRG's ROE of +0.18%. Regarding short-term risk, TFX is less volatile compared to ISRG. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ISRG's competition here
Becton, Dickinson and Company (NYSE: BDXA)
TFX vs BDXA Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BDXA's P/E ratio is 45.70. In terms of profitability, TFX's ROE is -0.32%, compared to BDXA's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to BDXA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BDXA's competition here
Becton, Dickinson and Company (NYSE: BDX)
TFX vs BDX Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BDX has a market cap of 51.7B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BDX trades at $189.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BDX's P/E ratio is 14.43. In terms of profitability, TFX's ROE is -0.32%, compared to BDX's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to BDX. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BDX's competition here
Medline Inc. (NASDAQ: MDLN)
TFX vs MDLN Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, MDLN has a market cap of 28.7B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while MDLN trades at $32.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas MDLN's P/E ratio is 24.85. In terms of profitability, TFX's ROE is -0.32%, compared to MDLN's ROE of +0.05%. Regarding short-term risk, TFX is less volatile compared to MDLN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
TFX vs WST Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, WST has a market cap of 24.8B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while WST trades at $356.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas WST's P/E ratio is 44.29. In terms of profitability, TFX's ROE is -0.32%, compared to WST's ROE of +0.19%. Regarding short-term risk, TFX is less volatile compared to WST. This indicates lower risk in terms of short-term price fluctuations for TFX.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
TFX vs HOLX Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas HOLX's P/E ratio is 31.54. In terms of profitability, TFX's ROE is -0.32%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, TFX is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for TFX.Check HOLX's competition here
Solventum Corporation (NYSE: SOLV)
TFX vs SOLV Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, SOLV has a market cap of 15.2B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while SOLV trades at $89.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas SOLV's P/E ratio is 12.37. In terms of profitability, TFX's ROE is -0.32%, compared to SOLV's ROE of +0.29%. Regarding short-term risk, TFX is less volatile compared to SOLV. This indicates lower risk in terms of short-term price fluctuations for TFX.Check SOLV's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
TFX vs COO Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, COO has a market cap of 15B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while COO trades at $76.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas COO's P/E ratio is 16.83. In terms of profitability, TFX's ROE is -0.32%, compared to COO's ROE of +0.03%. Regarding short-term risk, TFX is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for TFX.Check COO's competition here
Baxter International Inc. (NYSE: BAX)
TFX vs BAX Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BAX has a market cap of 13.8B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BAX trades at $26.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BAX's P/E ratio is 12.82. In terms of profitability, TFX's ROE is -0.32%, compared to BAX's ROE of -0.17%. Regarding short-term risk, TFX is less volatile compared to BAX. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BAX's competition here
Becton, Dickinson and Company (NYSE: BDXB)
TFX vs BDXB Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BDXB's P/E ratio is 7.60. In terms of profitability, TFX's ROE is -0.32%, compared to BDXB's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to BDXB. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BDXB's competition here
Repligen Corporation (NASDAQ: RGEN)
TFX vs RGEN Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, RGEN has a market cap of 10B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while RGEN trades at $183.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas RGEN's P/E ratio is 97.98. In terms of profitability, TFX's ROE is -0.32%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, TFX is less volatile compared to RGEN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check RGEN's competition here
Avantor, Inc. (NYSE: AVTR)
TFX vs AVTR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, AVTR has a market cap of 9.5B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while AVTR trades at $14.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas AVTR's P/E ratio is 16.44. In terms of profitability, TFX's ROE is -0.32%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, TFX is less volatile compared to AVTR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check AVTR's competition here
AptarGroup, Inc. (NYSE: ATR)
TFX vs ATR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ATR has a market cap of 8.5B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ATR trades at $132.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ATR's P/E ratio is 23.24. In terms of profitability, TFX's ROE is -0.32%, compared to ATR's ROE of +0.14%. Regarding short-term risk, TFX is less volatile compared to ATR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ATR's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
TFX vs BLCO Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BLCO has a market cap of 6.2B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BLCO trades at $17.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BLCO's P/E ratio is 26.85. In terms of profitability, TFX's ROE is -0.32%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, TFX is less volatile compared to BLCO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
TFX vs STVN Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, STVN has a market cap of 5.9B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while STVN trades at $22.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas STVN's P/E ratio is 32.92. In terms of profitability, TFX's ROE is -0.32%, compared to STVN's ROE of +0.09%. Regarding short-term risk, TFX is less volatile compared to STVN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
TFX vs MMSI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, MMSI has a market cap of 5.5B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while MMSI trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas MMSI's P/E ratio is 23.52. In terms of profitability, TFX's ROE is -0.32%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, TFX is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
TFX vs ICUI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ICUI has a market cap of 4.7B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ICUI trades at $185.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ICUI's P/E ratio is 23.38. In terms of profitability, TFX's ROE is -0.32%, compared to ICUI's ROE of +0.01%. Regarding short-term risk, TFX is less volatile compared to ICUI. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ICUI's competition here
Envista Holdings Corp (NYSE: NVST)
TFX vs NVST Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NVST has a market cap of 4.5B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NVST trades at $27.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NVST's P/E ratio is 18.93. In terms of profitability, TFX's ROE is -0.32%, compared to NVST's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to NVST. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NVST's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
TFX vs PLSE Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, PLSE has a market cap of 3.3B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while PLSE trades at $47.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas PLSE's P/E ratio is -39.85. In terms of profitability, TFX's ROE is -0.32%, compared to PLSE's ROE of -0.94%. Regarding short-term risk, TFX is less volatile compared to PLSE. This indicates lower risk in terms of short-term price fluctuations for TFX.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
TFX vs ATRC Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ATRC has a market cap of 2.4B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ATRC trades at $47.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ATRC's P/E ratio is 1478.57. In terms of profitability, TFX's ROE is -0.32%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, TFX is less volatile compared to ATRC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ATRC's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
TFX vs XRAY Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, XRAY has a market cap of 2.2B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while XRAY trades at $10.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas XRAY's P/E ratio is 7.71. In terms of profitability, TFX's ROE is -0.32%, compared to XRAY's ROE of -0.40%. Regarding short-term risk, TFX is less volatile compared to XRAY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
TFX vs LMAT Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, LMAT has a market cap of 1.9B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while LMAT trades at $82.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas LMAT's P/E ratio is 30.83. In terms of profitability, TFX's ROE is -0.32%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, TFX is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for TFX.Check LMAT's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
TFX vs BLFS Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, BLFS has a market cap of 1.8B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while BLFS trades at $37.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas BLFS's P/E ratio is -172.56. In terms of profitability, TFX's ROE is -0.32%, compared to BLFS's ROE of +0.13%. Regarding short-term risk, TFX is less volatile compared to BLFS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
TFX vs AZTA Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, AZTA has a market cap of 1.6B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while AZTA trades at $36.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas AZTA's P/E ratio is 84.81. In terms of profitability, TFX's ROE is -0.32%, compared to AZTA's ROE of -0.08%. Regarding short-term risk, TFX is less volatile compared to AZTA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
TFX vs KMTS Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, KMTS has a market cap of 1.6B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while KMTS trades at $27.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas KMTS's P/E ratio is -11.83. In terms of profitability, TFX's ROE is -0.32%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, TFX is less volatile compared to KMTS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
TFX vs STAA Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while STAA trades at $23.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas STAA's P/E ratio is 43.26. In terms of profitability, TFX's ROE is -0.32%, compared to STAA's ROE of +0.01%. Regarding short-term risk, TFX is less volatile compared to STAA. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
TFX vs QDEL Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, QDEL has a market cap of 941M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while QDEL trades at $14.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas QDEL's P/E ratio is 10.30. In terms of profitability, TFX's ROE is -0.32%, compared to QDEL's ROE of -0.55%. Regarding short-term risk, TFX is less volatile compared to QDEL. This indicates lower risk in terms of short-term price fluctuations for TFX.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
TFX vs ATRI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ATRI's P/E ratio is 64.50. In terms of profitability, TFX's ROE is -0.32%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, TFX is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
TFX vs ANGO Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ANGO has a market cap of 664.2M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ANGO trades at $15.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ANGO's P/E ratio is -41.21. In terms of profitability, TFX's ROE is -0.32%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, TFX is less volatile compared to ANGO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
TFX vs NNNN Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NNNN has a market cap of 366.5M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NNNN trades at $7.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NNNN's P/E ratio is 120.66. In terms of profitability, TFX's ROE is -0.32%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, TFX is less volatile compared to NNNN. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NNNN's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
TFX vs SMTI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, SMTI has a market cap of 315.1M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while SMTI trades at $34.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas SMTI's P/E ratio is -571.33. In terms of profitability, TFX's ROE is -0.32%, compared to SMTI's ROE of -4.74%. Regarding short-term risk, TFX is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for TFX.Check SMTI's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
TFX vs OSUR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, OSUR has a market cap of 258.2M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while OSUR trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas OSUR's P/E ratio is -6.82. In terms of profitability, TFX's ROE is -0.32%, compared to OSUR's ROE of -0.15%. Regarding short-term risk, TFX is less volatile compared to OSUR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check OSUR's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
TFX vs INFU Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, INFU has a market cap of 245.8M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while INFU trades at $12.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas INFU's P/E ratio is 29.71. In terms of profitability, TFX's ROE is -0.32%, compared to INFU's ROE of +0.15%. Regarding short-term risk, TFX is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for TFX.Check INFU's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
TFX vs UTMD Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, UTMD has a market cap of 229.6M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while UTMD trades at $73.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas UTMD's P/E ratio is 21.34. In terms of profitability, TFX's ROE is -0.32%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, TFX is less volatile compared to UTMD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check UTMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
TFX vs PDEX Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, PDEX has a market cap of 213.7M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while PDEX trades at $66.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas PDEX's P/E ratio is 23.57. In terms of profitability, TFX's ROE is -0.32%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, TFX is less volatile compared to PDEX. This indicates lower risk in terms of short-term price fluctuations for TFX.Check PDEX's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
TFX vs KRMD Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, KRMD has a market cap of 152.5M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while KRMD trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas KRMD's P/E ratio is -83.00. In terms of profitability, TFX's ROE is -0.32%, compared to KRMD's ROE of -0.11%. Regarding short-term risk, TFX is less volatile compared to KRMD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check KRMD's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
TFX vs MBOT Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, MBOT has a market cap of 70.6M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while MBOT trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas MBOT's P/E ratio is -5.96. In terms of profitability, TFX's ROE is -0.32%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, TFX is less volatile compared to MBOT. This indicates lower risk in terms of short-term price fluctuations for TFX.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
TFX vs AKYA Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas AKYA's P/E ratio is -1.34. In terms of profitability, TFX's ROE is -0.32%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, TFX is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for TFX.Check AKYA's competition here
Daxor Corporation (NASDAQ: DXR)
TFX vs DXR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, DXR has a market cap of 60.1M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while DXR trades at $10.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas DXR's P/E ratio is 5.67. In terms of profitability, TFX's ROE is -0.32%, compared to DXR's ROE of +0.22%. Regarding short-term risk, TFX is less volatile compared to DXR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check DXR's competition here
SkyAI, Inc. (NASDAQ: STSS)
TFX vs STSS Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, STSS has a market cap of 53.7M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while STSS trades at $1.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas STSS's P/E ratio is -0.02. In terms of profitability, TFX's ROE is -0.32%, compared to STSS's ROE of -1.54%. Regarding short-term risk, TFX is less volatile compared to STSS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check STSS's competition here
Nephros, Inc. (NASDAQ: NEPH)
TFX vs NEPH Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NEPH has a market cap of 51.7M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NEPH trades at $4.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NEPH's P/E ratio is 79.33. In terms of profitability, TFX's ROE is -0.32%, compared to NEPH's ROE of +0.16%. Regarding short-term risk, TFX is less volatile compared to NEPH. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NEPH's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
TFX vs OMIC Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas OMIC's P/E ratio is -0.58. In terms of profitability, TFX's ROE is -0.32%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, TFX is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for TFX.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
TFX vs IGAP Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas IGAP's P/E ratio is -10.52. In terms of profitability, TFX's ROE is -0.32%, compared to IGAP's ROE of +1.80%. Regarding short-term risk, TFX is less volatile compared to IGAP. This indicates lower risk in terms of short-term price fluctuations for TFX.Check IGAP's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
TFX vs POCI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, POCI has a market cap of 48.6M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while POCI trades at $4.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas POCI's P/E ratio is -6.17. In terms of profitability, TFX's ROE is -0.32%, compared to POCI's ROE of -0.37%. Regarding short-term risk, TFX is less volatile compared to POCI. This indicates lower risk in terms of short-term price fluctuations for TFX.Check POCI's competition here
Milestone Scientific Inc. (AMEX: MLSS)
TFX vs MLSS Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, MLSS has a market cap of 42.4M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while MLSS trades at $0.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas MLSS's P/E ratio is -7.99. In terms of profitability, TFX's ROE is -0.32%, compared to MLSS's ROE of -1.49%. Regarding short-term risk, TFX is less volatile compared to MLSS. This indicates lower risk in terms of short-term price fluctuations for TFX.Check MLSS's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
TFX vs HBIO Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, HBIO has a market cap of 31.9M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while HBIO trades at $7.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas HBIO's P/E ratio is -19.67. In terms of profitability, TFX's ROE is -0.32%, compared to HBIO's ROE of -0.92%. Regarding short-term risk, TFX is less volatile compared to HBIO. This indicates lower risk in terms of short-term price fluctuations for TFX.Check HBIO's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
TFX vs SDC Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas SDC's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to SDC's ROE of -1.96%. Regarding short-term risk, TFX is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check SDC's competition here
Invacare Corporation (NYSE: IVC)
TFX vs IVC Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas IVC's P/E ratio is -0.79. In terms of profitability, TFX's ROE is -0.32%, compared to IVC's ROE of -0.46%. Regarding short-term risk, TFX is less volatile compared to IVC. This indicates lower risk in terms of short-term price fluctuations for TFX.Check IVC's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
TFX vs ZJYL Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ZJYL has a market cap of 24.1M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ZJYL trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ZJYL's P/E ratio is 19.25. In terms of profitability, TFX's ROE is -0.32%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, TFX is less volatile compared to ZJYL. This indicates lower risk in terms of short-term price fluctuations for TFX.Check ZJYL's competition here
Retractable Technologies, Inc. (AMEX: RVP)
TFX vs RVP Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, RVP has a market cap of 21.7M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while RVP trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas RVP's P/E ratio is -2.20. In terms of profitability, TFX's ROE is -0.32%, compared to RVP's ROE of -0.05%. Regarding short-term risk, TFX is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for TFX.Check RVP's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
TFX vs RGNT Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, RGNT has a market cap of 15.6M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while RGNT trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas RGNT's P/E ratio is -0.09. In terms of profitability, TFX's ROE is -0.32%, compared to RGNT's ROE of N/A. Regarding short-term risk, TFX is less volatile compared to RGNT. This indicates lower risk in terms of short-term price fluctuations for TFX.Check RGNT's competition here
Femasys Inc. (NASDAQ: FEMY)
TFX vs FEMY Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, FEMY has a market cap of 7.9M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while FEMY trades at $2.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas FEMY's P/E ratio is -7.21. In terms of profitability, TFX's ROE is -0.32%, compared to FEMY's ROE of -2.26%. Regarding short-term risk, TFX is less volatile compared to FEMY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check FEMY's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
TFX vs NSTG Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NSTG's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, TFX is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NSTG's competition here
Lucyd, Inc (NASDAQ: LUCY)
TFX vs LUCY Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, LUCY has a market cap of 4.4M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while LUCY trades at $0.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas LUCY's P/E ratio is -0.41. In terms of profitability, TFX's ROE is -0.32%, compared to LUCY's ROE of -0.89%. Regarding short-term risk, TFX is less volatile compared to LUCY. This indicates lower risk in terms of short-term price fluctuations for TFX.Check LUCY's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
TFX vs POAI Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas POAI's P/E ratio is -0.03. In terms of profitability, TFX's ROE is -0.32%, compared to POAI's ROE of -21.19%. Regarding short-term risk, TFX is less volatile compared to POAI. This indicates lower risk in terms of short-term price fluctuations for TFX.Check POAI's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
TFX vs NXGL Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NXGL has a market cap of 3.3M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NXGL trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NXGL's P/E ratio is -0.55. In terms of profitability, TFX's ROE is -0.32%, compared to NXGL's ROE of -1.33%. Regarding short-term risk, TFX is less volatile compared to NXGL. This indicates lower risk in terms of short-term price fluctuations for TFX.Check NXGL's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
TFX vs GCTK Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, GCTK has a market cap of 2.7M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while GCTK trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas GCTK's P/E ratio is -0.02. In terms of profitability, TFX's ROE is -0.32%, compared to GCTK's ROE of -21.36%. Regarding short-term risk, TFX is less volatile compared to GCTK. This indicates lower risk in terms of short-term price fluctuations for TFX.Check GCTK's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
TFX vs MHUA Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas MHUA's P/E ratio is 0.25. In terms of profitability, TFX's ROE is -0.32%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, TFX is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for TFX.Check MHUA's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVD)
TFX vs GMVD Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, GMVD has a market cap of 1.8M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while GMVD trades at $0.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas GMVD's P/E ratio is -0.01. In terms of profitability, TFX's ROE is -0.32%, compared to GMVD's ROE of +2.09%. Regarding short-term risk, TFX is less volatile compared to GMVD. This indicates lower risk in terms of short-term price fluctuations for TFX.Check GMVD's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
TFX vs GMVDW Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas GMVDW's P/E ratio is N/A. In terms of profitability, TFX's ROE is -0.32%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, TFX is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for TFX.Check GMVDW's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
TFX vs NXGLW Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, NXGLW has a market cap of 1.5M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas NXGLW's P/E ratio is -0.05. In terms of profitability, TFX's ROE is -0.32%, compared to NXGLW's ROE of -1.33%. Regarding short-term risk, TFX is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for TFX.Check NXGLW's competition here
Avinger, Inc. (NASDAQ: AVGR)
TFX vs AVGR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas AVGR's P/E ratio is -0.05. In terms of profitability, TFX's ROE is -0.32%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, TFX is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for TFX.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
TFX vs LUCYW Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas LUCYW's P/E ratio is N/A. In terms of profitability, TFX's ROE is -0.32%, compared to LUCYW's ROE of -0.89%. Regarding short-term risk, TFX is less volatile compared to LUCYW. This indicates lower risk in terms of short-term price fluctuations for TFX.Check LUCYW's competition here
Invuity, Inc. (NASDAQ: IVTY)
TFX vs IVTY Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, IVTY has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas IVTY's P/E ratio is -3.80. In terms of profitability, TFX's ROE is -0.32%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, TFX is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for TFX.Check IVTY's competition here
Analogic Corporation (NASDAQ: ALOG)
TFX vs ALOG Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ALOG has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ALOG's P/E ratio is 40.93. In terms of profitability, TFX's ROE is -0.32%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, TFX is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ALOG's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
TFX vs HRC Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, HRC has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas HRC's P/E ratio is 41.92. In terms of profitability, TFX's ROE is -0.32%, compared to HRC's ROE of +0.14%. Regarding short-term risk, TFX is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for TFX.Check HRC's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
TFX vs ATRS Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, ATRS has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas ATRS's P/E ratio is 14.95. In terms of profitability, TFX's ROE is -0.32%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, TFX is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for TFX.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
TFX vs APR Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, APR has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas APR's P/E ratio is 22.59. In terms of profitability, TFX's ROE is -0.32%, compared to APR's ROE of +9.81%. Regarding short-term risk, TFX is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for TFX.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
TFX vs IIN Comparison August 2026
Teleflex Incorporated (NYSE: TFX) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TFX stands at 6B. In comparison, IIN has a market cap of 0. Regarding current trading prices, TFX is priced at $136.27 on the NYSE, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TFX currently has a P/E ratio of 15.54, whereas IIN's P/E ratio is 226.45. In terms of profitability, TFX's ROE is -0.32%, compared to IIN's ROE of -0.00%. Regarding short-term risk, TFX is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for TFX.Check IIN's competition here